Deerfield Management Company, L.P. (Series C) Alector, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Alector, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,055,192 shares of ALEC stock, worth $1.49 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,055,192
Previous 1,066,962
1.1%
Holding current value
$1.49 Million
Previous $2.02 Million
35.66%
% of portfolio
0.03%
Previous 0.05%
Shares
13 transactions
Others Institutions Holding ALEC
# of Institutions
147Shares Held
55.5MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$13.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$8.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$2.77 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$2.31 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $116M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...